MedPath

Albimmune SL

🇪🇸Spain
Ownership
Private
Employees
-
Market Cap
-
Website

Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure.

Phase 2
Withdrawn
Conditions
Septic Shock
Interventions
Other: Saline solution
First Posted Date
2022-12-12
Last Posted Date
2024-07-31
Lead Sponsor
Albimmune SL
Registration Number
NCT05645887
© Copyright 2025. All Rights Reserved by MedPath